Calidi Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calidi Biotherapeutics, Inc. has filed 406 SEC EDGAR filings since 17 May 2021

SEC filing history

Showing 376-400 of 406 matching filings.

Per page
25
Current page
16
SC 13G File 005-92875

FIRST LIGHT ACQUISITION GROUP, INC.

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

SC 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

FORM SC 13G

Filing date
08 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92875

FIRST LIGHT ACQUISITION GROUP, INC.

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40789

8-K

Filing date
28 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

SC 13G filing

Filing date
26 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

SC 13G

Filing date
24 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

FIRST LIGHT ACQUISITION GROUP, INC.

Filing date
24 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

SCHEDULE 13G

Filing date
24 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40789

8-K

Filing date
20 Sep 2021
Reporting date
14 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40789

8-K

Filing date
15 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A

Filing date
14 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-259038

424B4

Filing date
13 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259038

EFFECT filing

Filing date
09 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-40789

NYSE CERTIFICATION

Filing date
09 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-40789

8-A12B

Filing date
09 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .